NEXT Scientist publishes paper: Microsatellite Instability Analysis (MSA) for Bladder Cancer: Past History and Future Directions
Chulso Moon 1,2,3, Maxie Gordon 2,3, David Moon 2 and Thomas Reynolds* 4 Citation: Moon, C.; Gordon, M.; Moon, D.; Reynolds, T....
L-asparaginase chemotherapy is integral in the treatment of pediatric, adolescent, and young adult (AYA) patients with Acute Lymphoblastic Leukemia (ALL). Its incorporation, as part of a multi-agent c
L-asparaginase chemotherapy is integral in the treatment of pediatric, adolescent, and young adult (AYA) patients with Acute...
NEXT Scientists contribute to paper on pharmacogenomics of CYP450 genes
Chester, VA. NEXT Molecular Analytics (NEXT) announces the publication of a large pharmacogenomics clinical study involving Next...
NEXT Molecular Analytics Receives Accreditation from the New York State Department of Health for its L-Asparaginase Enzyme Activity Assay Platform
CHESTER, VA (June 9, 2022). NEXT Bio Research Services LLC ( www.nextmolecular.com ), dba NEXT Molecular Analytics is pleased to announce...
Oxford BioDynamics announces US launch of its Checkpoint Inhibitor Response Test (EpiSwitch® CiRT) foroncology
Checkpoint Inhibitor Response Test (EpiSwitch® CiRT) for oncology First-of-its-kind precision medicine test to predict a cancer patent's...
Richmond Times-Dispatch Article about NEXT Molecular Analytics
NEXT Molecular Analytics article in the business section of the Richmond Times-Dispatch.
NEXT to Present Keynote Presentation on Precision Medicine
NEXT Bio-Research Service’s CMO and Laboratory Director, Dai “Dave” J. Li, MD, MSc., Ph.D., FACB to present Keynote presentation on...
NEXT BIO-RESEARCH SERVICES LLC BEGINS OPERATIONS
NEXT BIO-RESEARCH SERVICES LLC BEGINS OPERATIONS Company Offers Esoteric Clinical Tests and Fundamental Research in the Life Sciences...
